HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
171419.0,259757,2203-11-04 06:45:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   ROS: Pt complains of right elbow pain.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99% on 4L
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA)
   - will place swan to assess fluid status. For now  on milrinone at
   0.75mcg/kg/min and furosemide 20mg/hr.
   - continue bblocker 6.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE, continue dig (level recently 1.3)
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Will touch base with Dr [**Last Name (STitle) **] (outpt hematologist) to reassess
   prognosis in setting of CHF for ? involvement of palliative care and ?
   need for inpt consult.
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   ROS: Pt complains of right elbow pain.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99% on 4L
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA)
   - will place swan to assess fluid status. For now  on milrinone at
   0.75mcg/kg/min and furosemide 20mg/hr.
   - continue bblocker 6.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE, continue dig (level recently 1.3)
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Will touch base with Dr [**Last Name (STitle) **] (outpt hematologist) to reassess
   prognosis in setting of CHF for ? involvement of palliative care and ?
   need for inpt consult.
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 68-year-old female with a complex medical history, including coronary artery disease (CAD) with previous 4-vessel coronary artery bypass grafting (CABG) and stenting of the left internal mammary artery (LIMA) to the left anterior descending (LAD) artery. She also has severe chronic heart failure (CHF) with an estimated ejection fraction (EF) of 20-30%. The patient was recently discharged but presented with acute on chronic renal failure, requiring admission to the intensive care unit (ICU).

The patient's current vital signs include a temperature of 37.2°C, heart rate of 84 beats per minute, blood pressure of 94/46 mmHg, and oxygen saturation of 99% on 4 liters of oxygen. She is on mechanical ventilation and has a Swan-Ganz catheter in place to monitor her fluid status.

The patient's physical examination reveals bilateral elbow swelling with point tenderness at the point of tendon insertion to the humerus. She also has multiple areas of hyperpigmentation on her skin.

Laboratory results show:

* White blood cell count (WBC): 1.6-2.0 K/uL
* Hematocrit (Hct): 27.0-23.5%
* Platelet count (Plt): 121-115 K/uL
* Creatinine (Cr): 2.2-2.7 mg/dL
* Blood urea nitrogen (BUN): 23 mEq/L
* Sodium (Na): 135-132 mg/dL
* Potassium (K): 4.0-4.3 mEq/L
* Chloride (Cl): 93-100 mg/dL
* Calcium (Ca++): 8.7-8.5 mg/dL
* Magnesium (Mg++): 2.2-2.5 mg/dL
* Phosphorus (PO4): 4.3-4.5 mg/dL

The patient is currently receiving several medications, including:

* Milrinone: 0.75 mcg/kg/min IV drip infusion
* Furosemide: 20 mg/hr IV drip
* Digoxin: 0.125 mg PO 3 times a week
* Metoprolol: 6.25 mg PO bid
* Heparin: 5000 units SC tid
* Insulin: SC QID FS
* Pravastatin: 20 mg PO daily
* Aspirin: 81 mg PO daily
* Clopidogrel: 75 mg PO daily
* Multivitamins: 1 tablet PO daily
* Nitroglycerin: 0.3 mg SL prn
* Ondansetron: 4 mg IV q8h:prn nausea
* Bisacodyl: 10 mg PO daily:prn
* Senna: 1 tablet PO bid:prn
* Epoetin alfa: 3000 units SC qmo wefr
* Acetaminophen: 325-650 mg PO q6h:prn
* Fluticasone propionate: 110 mcg 2 puffs IH daily
* Albuterol MDI: 2 puffs IH q6h:prn
* TraMADOL (Ultram): 50 mg PO bid:prn foot pain
* Tiotropium bromide: 1 capsule IH daily
* TraZODONE: 25 mg PO hs:prn insomnia

Potential medical complications that can arise from this patient's condition include:

1. Worsening of acute on chronic renal failure: The patient's creatinine level is elevated, and her potassium and phosphorus levels are abnormal. This may require further adjustments to her medication regimen and fluid management.
2. Decreased cardiac output: The patient's severe CHF and low EF may lead to decreased cardiac output, which can worsen her renal function and increase her risk of mortality.
3. Infection: The patient's immune system may be compromised due to her CHF and renal failure, making her more susceptible to infections.
4. Bleeding: The patient's platelet count is low, and she is receiving anticoagulation therapy with heparin. This may increase her risk of bleeding.
5. Hypotension: The patient's blood pressure is low, and her cardiac output may be compromised. This may require further adjustments to her medication regimen and fluid management.
6. Elbow pain: The patient's elbow pain may be due to a variety of causes, including gout, pseudogout, or bursitis. Further evaluation and management are necessary to determine the underlying cause of her pain.

In conclusion, the patient is a complex case with multiple medical conditions requiring careful management to prevent further complications."
171419.0,259757,2203-11-04 06:45:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female, sleepy but cooperative. A+O x 3
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Oral mucosa moist.
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding. Abd aorta not enlarged by palpation.
   No abdominial bruits.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.
   SKIN: Multiple areas of hyperpigmentation
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone
   [**11-2**] [**Doctor Last Name **] recs
   - start milrinone: give 50mcg/kg bolus over 15 minutes, then start
   0.375mcg/kg/min titrate to goal 0.5mcg/kg/min. Will titrate to urine
   output, decrease edema, Cr decrease
   - Start milrinone 30min prior to administering lasix
   - Give lasix 60mg IV x 1 and start drip at 7micrograms/hr.
   - Goal 1L negative
   - continue bblocker 12.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os
   - Daily Weights
   - Continue Digoxin
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva
   - Continue Albuterol
   - Continue Fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Continue to monitor
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female, sleepy but cooperative. A+O x 3
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Oral mucosa moist.
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding. Abd aorta not enlarged by palpation.
   No abdominial bruits.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.
   SKIN: Multiple areas of hyperpigmentation
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone
   [**11-2**] [**Doctor Last Name **] recs
   - start milrinone: give 50mcg/kg bolus over 15 minutes, then start
   0.375mcg/kg/min titrate to goal 0.5mcg/kg/min. Will titrate to urine
   output, decrease edema, Cr decrease
   - Start milrinone 30min prior to administering lasix
   - Give lasix 60mg IV x 1 and start drip at 7micrograms/hr.
   - Goal 1L negative
   - continue bblocker 12.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os
   - Daily Weights
   - Continue Digoxin
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva
   - Continue Albuterol
   - Continue Fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Continue to monitor
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is a 68-year-old female with a complex medical history, including:

* Coronary artery disease (CAD) with a history of 4-vessel coronary artery bypass grafting (CABG) and follow-up stent placement in the left anterior descending (LAD) artery
* Severe chronic heart failure (CHF) with an ejection fraction (EF) of 20-30%
* Recent discharge with acute on chronic renal failure, with a creatinine level of 2.7 mg/dL
* History of asthma, anemia/myelodysplastic syndrome, and diabetes mellitus (DM)

The patient is currently in the intensive care unit (ICU) due to the severity of her condition. Her vital signs are:

* Temperature: 37.2°C (99°F)
* Heart rate: 84 beats per minute (bpm)
* Blood pressure: 94/46 mmHg
* Respiratory rate: 17 breaths per minute
* Oxygen saturation: 99%

The patient's physical examination is notable for:

* Generalized weakness and lethargy
* Normal cardiac examination, with a fixed split second heart sound
* No murmurs, thrills, or lifts
* No signs of congestive heart failure
* No abdominal tenderness or guarding
* No extremity edema

The patient's laboratory results are:

* Creatinine: 2.7 mg/dL
* Blood urea nitrogen (BUN): 23 mg/dL
* Glucose: 135 mg/dL
* White blood cell count (WBC): 1.6 K/uL
* Hemoglobin (Hb): 7.3 g/dL
* Platelet count (Plt): 121 K/uL

The patient is currently receiving the following medications:

* Milrinone: 0.75 mcg/kg/min IV drip infusion
* Furosemide: 20 mg/hr IV drip
* Lasix: 60 mg IV x 1, then 7 micrograms/hr IV drip
* Dobutamine: 50 mcg/kg bolus over 15 minutes, then 0.375 mcg/kg/min titrate to goal 0.5 mcg/kg/min
* Digoxin: 0.125 mg PO 3x/week
* Metoprolol: 12.5 mg PO bid
* Insulin: SS w/ QID FS
* Pravastatin: 20 mg PO daily
* Heparin: 5000 unit SC tid
* Aspirin: 81 mg PO daily
* Clopidogrel: 75 mg PO daily
* Multivitamins: 1 tablet PO daily
* Ondansetron: 4 mg IV q8h:prn nausea
* Bisacodyl: 10 mg PO daily:prn
* Epoetin alfa: 3000 unit SC qmo week
* Fluticasone propionate: 110 mcg 2 puffs IH q6h:prn
* Albuterol: 2 puffs IH q6h:prn
* Tiotropium bromide: 1 cap IH daily
* TraMADOL (Ultram): 50 mg PO bid:prn foot pain
* TraZODONE: 25 mg PO hs:prn insomnia

Potential medical complications that can arise from the patient's condition include:

* Cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia
* Cardiac failure, including acute decompensated heart failure
* Renal failure, including acute kidney injury or chronic kidney disease
* Respiratory failure, including acute respiratory distress syndrome (ARDS)
* Neurological complications, such as stroke or seizures
* Infection, including pneumonia or sepsis
* Bleeding, including gastrointestinal bleeding or hemorrhagic stroke

Given the patient's complex medical history and current condition, it is essential to closely monitor her vital signs, laboratory results, and medication regimen to prevent and manage potential complications."
171419.0,259757,2203-11-05 06:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   VT on tele ~ 20 s runs.  Assymptomatic
   S:  Feels better.  Still c/o elbow pain but that is slightly improved.
   No CP, SOB
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
                                     131
                               [image002.gif]
                                     94
                               [image002.gif]
                                     99
   [image004.gif]
   124
                                                                   AGap=17
   [image005.gif]
   3.8
                               [image002.gif]
                                     24
                               [image002.gif]
                                     2.7
   [image007.gif]
   Mg: 2.2
   Source: Line-picc
   0
                                                                       2.0
                                                            [image007.gif]
                                     0 D
   [image004.gif]
   118
                 [image008.gif]
   [image004.gif]
                                     27
   [image007.gif]
   Source: [**Name (NI) 2419**]
   PT: 15.3
   PTT: 28.3
   INR: 1.3
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday.  Has
   ICD.
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Improved following gentle rehydration
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU while on milrinone
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   VT on tele ~ 20 s runs.  Assymptomatic
   S:  Feels better.  Still c/o elbow pain but that is slightly improved.
   No CP, SOB
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
                                     131
                               [image002.gif]
                                     94
                               [image002.gif]
                                     99
   [image004.gif]
   124
                                                                   AGap=17
   [image005.gif]
   3.8
                               [image002.gif]
                                     24
                               [image002.gif]
                                     2.7
   [image007.gif]
   Mg: 2.2
   Source: Line-picc
   0
                                                                       2.0
                                                            [image007.gif]
                                     0 D
   [image004.gif]
   118
                 [image008.gif]
   [image004.gif]
                                     27
   [image007.gif]
   Source: [**Name (NI) 2419**]
   PT: 15.3
   PTT: 28.3
   INR: 1.3
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday.  Has
   ICD.
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Improved following gentle rehydration
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU while on milrinone
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 68-year-old female with a complex medical history, including:

* Coronary artery disease (CAD) with a history of 4-vessel CABG and stenting
* Severe congestive heart failure (CHF) with an ejection fraction of 20-30%
* Acute on chronic renal failure
* Myelodysplastic syndrome (MDS)
* Anemia
* Diabetes mellitus (DM)
* Asthma
* Elbow pain of unclear etiology

The patient was admitted to the ICU for further management of her condition. The note highlights the following key points:

* The patient's renal function has improved following gentle rehydration
* The patient's heart rhythm is currently ventricular-paced
* The patient's electrolytes are being monitored and corrected as needed
* The patient is being treated with various medications, including ASA, statin, Plavix, low-dose beta-blocker, and milrinone
* The patient's pain is being managed with Tylenol as needed
* The patient's respiratory status is stable, with an SpO2 of 96%

Potential medical complications that can arise include:

* Worsening of renal function
* Further decline in cardiac function
* Development of arrhythmias or cardiac conduction disturbances
* Respiratory failure
* Infection
* Gastrointestinal bleeding
* Poor wound healing due to impaired circulation

The patient's treatment plan includes:

* Continued management of her CAD with ASA, statin, and Plavix
* Ongoing treatment of her CHF with milrinone and beta-blocker
* Monitoring of her renal function and electrolytes
* Management of her pain and respiratory status
* Further evaluation and management of her elbow pain
* Ongoing treatment of her MDS and anemia
* Monitoring of her glucose levels and insulin therapy

The patient's prognosis is guarded due to her complex medical history and ongoing medical complications. Close monitoring and management of her condition are necessary to prevent further complications and improve her overall outcome."
171419.0,259757,2203-11-05 06:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   VT on tele.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Creatinine continues to rise.  Will
   rehydrate to lower.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU team for now
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   VT on tele.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Creatinine continues to rise.  Will
   rehydrate to lower.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU team for now
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 68-year-old female with a complex medical history, including:

* Coronary artery disease (CAD) with a history of 4-vessel coronary artery bypass grafting (CABG) and stenting of the left internal mammary artery to the left anterior descending artery (LIMA-LAD)
* Severe chronic heart failure (CHF) with an ejection fraction of 20-30%
* Acute on chronic renal failure, with rising creatinine levels
* Anemia/myelodysplastic syndrome (MDS) at baseline
* Elbow pain of unclear etiology
* Diabetes mellitus (DM) with insulin dependence
* Asthma

The patient was admitted to the Intensive Care Unit (ICU) with a diagnosis of acute on chronic renal failure, CHF, and MDS. She has a history of recent discharge with a follow-up stent, and was readmitted with worsening symptoms.

The patient's current condition is:

* Hemodynamically unstable with a blood pressure of 99/46 mmHg and a heart rate of 88 bpm
* Respiratory support with oxygen therapy and non-invasive ventilation
* Renal failure with a creatinine level of 2.7 mg/dL
* Anemia with a hemoglobin level of 27.0 g/dL
* MDS with a platelet count of 121 x 10^9/L
* Elbow pain with unclear etiology
* Hyperpigmentation on the skin

The patient is receiving the following medications:

* Milrinone to augment diuresis and increase renal perfusion
* Dobutamine to support cardiac function
* Beta-blocker to control heart rate and blood pressure
* Insulin to manage blood sugar levels
* Albuterol to treat asthma
* Fluticasone to treat asthma
* Spiriva to treat asthma
* Tylenol to manage pain
* Ondansetron to manage nausea
* Potassium chloride to manage electrolyte imbalance
* Pravastatin to manage cholesterol levels
* Clopidogrel to prevent thrombosis
* Aspirin to prevent thrombosis
* Bisacodyl to manage constipation
* Senna to manage constipation
* Tiotropium bromide to manage chronic obstructive pulmonary disease (COPD)
* TraMADOL to manage foot pain
* TraZODONE to manage insomnia

Potential medical complications that may arise include:

* Further worsening of renal failure and electrolyte imbalance
* Increased risk of cardiac arrhythmias and cardiac arrest
* Respiratory failure and need for mechanical ventilation
* Increased risk of bleeding due to anticoagulant therapy
* Infection and sepsis
* Development of acute kidney injury (AKI) or chronic kidney disease (CKD)
* Increased risk of stroke and thromboembolism
* Development of respiratory failure and need for mechanical ventilation
* Increased risk of mortality due to underlying medical conditions and treatment complications."
171419.0,259757,2203-11-06 09:32:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
    Stopped milrinone drip, switched to PO lasix at home dose
   Allergies:
   Lipitor (Oral) Rash;
   Lisinopril Rash;
   Iodine Unknown;
   Paper Tape Rash;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2203-11-5**] 10:39 PM
   Other medications:
   Flowsheet Data as of  [**2203-11-6**] 09:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 35.4
C (95.7
   HR: 79 (65 - 95) bpm
   BP: 100/51(61) {93/51(61) - 121/80(84)} mmHg
   RR: 35 (16 - 35) insp/min
   SpO2: 98%
   Heart rhythm: V Paced
   Height: 61 Inch
                  Total In:
                                                                    711 mL
                  PO:
                                                                    290 mL
                  TF:
   IVF:
                                                                    421 mL
   Blood products:
   Total out:
                                                                  1,055 mL
                                                                    290 mL
   Urine:
                                                                  1,055 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -344 mL
                                                                   -290 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   110 K/uL
   8.1 g/dL
   102 mg/dL
   2.3 mg/dL
   22 mEq/L
   4.4 mEq/L
   97 mg/dL
   95 mEq/L
   132 mEq/L
   24.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
                            [**2203-11-5**]  05:51 AM
                            [**2203-11-5**]  07:41 PM
                            [**2203-11-6**]  06:28 AM
   WBC
   1.6
   2.0
   2.0
   2.0
   Hct
   27.0
   23.5
   27.0
   24.5
   Plt
   121
   115
   118
   110
   Cr
   2.2
   2.4
   2.7
   3.0
   2.7
   2.6
   2.3
   TropT
   0.54
   Glucose
   106
   235
   135
   124
   102
   Other labs: PT / PTT / INR:15.3/28.3/1.3, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.6 mg/dL, Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD. Currently thought to be total body
   fluid overloaded but pt tolerating well (lungs clear, satting well,
   comfortable), so switched to PO lasix to keep even to neg.
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes
   .
   # Acute on Chronic Renal Failure: Improving
   .
   # Asthma  - Continue Spiriva, albuterol, fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Transfuse as needed
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN   - Correct/Replete electrolytes PRN, no IVF, Diabetic/Cardiac
   diet
   # ACCESS: Right EJ
   # PROPHYLAXIS: SC Heparin, Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: to floor today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
    Stopped milrinone drip, switched to PO lasix at home dose
   Allergies:
   Lipitor (Oral) Rash;
   Lisinopril Rash;
   Iodine Unknown;
   Paper Tape Rash;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2203-11-5**] 10:39 PM
   Other medications:
   Flowsheet Data as of  [**2203-11-6**] 09:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 35.4
C (95.7
   HR: 79 (65 - 95) bpm
   BP: 100/51(61) {93/51(61) - 121/80(84)} mmHg
   RR: 35 (16 - 35) insp/min
   SpO2: 98%
   Heart rhythm: V Paced
   Height: 61 Inch
                  Total In:
                                                                    711 mL
                  PO:
                                                                    290 mL
                  TF:
   IVF:
                                                                    421 mL
   Blood products:
   Total out:
                                                                  1,055 mL
                                                                    290 mL
   Urine:
                                                                  1,055 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -344 mL
                                                                   -290 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   110 K/uL
   8.1 g/dL
   102 mg/dL
   2.3 mg/dL
   22 mEq/L
   4.4 mEq/L
   97 mg/dL
   95 mEq/L
   132 mEq/L
   24.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
                            [**2203-11-5**]  05:51 AM
                            [**2203-11-5**]  07:41 PM
                            [**2203-11-6**]  06:28 AM
   WBC
   1.6
   2.0
   2.0
   2.0
   Hct
   27.0
   23.5
   27.0
   24.5
   Plt
   121
   115
   118
   110
   Cr
   2.2
   2.4
   2.7
   3.0
   2.7
   2.6
   2.3
   TropT
   0.54
   Glucose
   106
   235
   135
   124
   102
   Other labs: PT / PTT / INR:15.3/28.3/1.3, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.6 mg/dL, Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD. Currently thought to be total body
   fluid overloaded but pt tolerating well (lungs clear, satting well,
   comfortable), so switched to PO lasix to keep even to neg.
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes
   .
   # Acute on Chronic Renal Failure: Improving
   .
   # Asthma  - Continue Spiriva, albuterol, fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Transfuse as needed
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN   - Correct/Replete electrolytes PRN, no IVF, Diabetic/Cardiac
   diet
   # ACCESS: Right EJ
   # PROPHYLAXIS: SC Heparin, Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: to floor today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 68-year-old female with a history of coronary artery disease (CAD) and severe chronic heart failure (CHF) with an ejection fraction of 20-30%. She has undergone four-vessel coronary artery bypass grafting (CABG) and has a stent in the left anterior descending (LAD) artery. She was recently discharged but presented with acute on chronic renal failure. Her vital signs are stable, with a heart rate of 79 beats per minute, blood pressure of 100/51 mmHg, and oxygen saturation of 98%. She is on several medications, including ASA, statin, Plavix, and low-dose beta blocker.

Physical examination reveals a well-dressed African-American female with no significant abnormalities except for multiple areas of hyperpigmentation on her skin. Her lungs are clear, and her abdomen is firm with no tenderness or guarding.

Laboratory results show elevated levels of creatinine (2.7 mg/dL) and potassium (4.4 mEq/L), indicating acute on chronic renal failure. Her white blood cell count is 1.6 K/uL, and her hemoglobin is 8.1 g/dL. Her platelet count is 121 K/uL.

Potential medical complications:

1. Worsening renal failure: The patient's creatinine level is increasing, and her potassium level is elevated, indicating worsening renal failure. This may lead to further electrolyte imbalances, acidosis, and cardiovascular instability.
2. Cardiac arrhythmias: The patient has a history of cardiac arrhythmias, including bradycardia, and may be at risk for further episodes, especially with her underlying heart failure and electrolyte imbalances.
3. Infection: The patient's white blood cell count is low, indicating potential immunosuppression. This may increase her risk of developing infections, especially with her history of cardiac surgery and chronic heart failure.
4. Anemia: The patient's hemoglobin level is low, indicating anemia. This may exacerbate her cardiac symptoms and increase her risk of cardiovascular events.
5. Electrolyte imbalances: The patient's potassium and magnesium levels are elevated, which may lead to cardiac arrhythmias, muscle weakness, and other symptoms. Her calcium level is normal, but her phosphate level is elevated, which may indicate hypocalcemia.
6. Gastrointestinal bleeding: The patient's history of gastrointestinal bleeding is not mentioned in the note, but her platelet count is normal, indicating a low risk of bleeding.
7. Thrombosis: The patient's history of coronary artery disease and cardiac surgery may increase her risk of developing thrombosis, especially with her use of anticoagulant medications.

Based on these findings, it is essential to continue monitoring the patient's vital signs, laboratory results, and cardiac function closely to prevent further complications. Adjustments to her medications and fluid management may be necessary to improve her cardiac function and renal function."
